Supplemental New Drug Application for at-home Igalmi aims to provide a self-administered option for agitation in schizophrenia and bipolar disorder.
An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.
The Medicity, Gurugram emphasize early diagnosis amid rising incidence of bradycardia: Our Bureau, Bengaluru Wednesday, April 1, 2026, 12:45 Hrs [IST] Medanta – The ...
With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the ...